Literature DB >> 12829041

Molecular diagnosis of zoster post varicella vaccination.

Andreas Sauerbrei1, B Uebe, P Wutzler.   

Abstract

BACKGROUND: Herpes zoster can be caused by endogenous reactivation of both wild-type virus or vaccine varicella-zoster virus (VZV) becoming latent within sensory ganglia after natural primary infection or varicella vaccination.
OBJECTIVES: To demonstrate molecular biological methods for reliable discrimination between wild-type VZV and vaccine strain Oka by an example of zoster in a vaccinated girl. STUDY
DESIGN: VZV was isolated from zoster occurring 16 months after varicella vaccination in a 2-year-old infant. Including VZV wild-type and different Oka strains as controls, viral DNA fragments located in the open reading frames (ORF) 38, 54, 62 and the R5 variable repeat region were characterized by amplification and restriction fragment length polymorphisms (RFLP) analysis.
RESULTS: VZV vaccine strain Oka was definitely proven to be the causative virus in this case of zoster post vaccination.
CONCLUSIONS: Molecular procedures for characterization of ORF 38 allow reliable discrimination between Oka-like and wild-type VZV outside Japan and Japanese communities. To distinguish Oka vaccine virus from Oka-like wild strains, analysis of DNA fragments located in the ORF 62 should be included.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829041     DOI: 10.1016/s1386-6532(03)00071-4

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  8 in total

1.  Stable and consistent genetic profile of Oka varicella vaccine virus is not linked with appearance of infrequent breakthrough cases postvaccination.

Authors:  Ventzislav Vassilev
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 2.  Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections.

Authors:  A Sauerbrei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

3.  Varicella-zoster virus at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Graciela Ordoñez; Benjamin Pineda
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.

Authors:  Andreas Sauerbrei; Elena Rubtcova; Peter Wutzler; D Scott Schmid; Vladimir N Loparev
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 5.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

6.  [Herpes zoster after varicella-zoster vaccination].

Authors:  M Fahlbusch; U Wesselmann; P Lehmann
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

7.  Genotyping of clinical varicella-zoster virus isolates collected in China.

Authors:  Jingjing Liu; Mingli Wang; Lin Gan; Sen Yang; Jason Chen
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

8.  Varicella Outbreak in an Indian Couple Living in Germany Caused by VZV Clade VI Acquired during a Trip to The Netherlands.

Authors:  Malgorzata Kolesnik; Bernd Bonnekoh; Ina Tammer; Harald Gollnick; Andreas Sauerbrei
Journal:  Case Rep Med       Date:  2012-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.